About: Lung Transplantation for Idiopathic Pulmonary Fibrosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lung Transplantation for Idiopathic Pulmonary Fibrosis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Lung Transplantation for Idiopathic Pulmonary Fibrosis
Creator	Lederer, David Lamas, Daniela
Source	PMC
abstract	Despite advances in the development of novel pharmaceutical agents to treat idiopathic pulmonary fibrosis (IPF), there are no medical therapies known to resolve fibrosis or improve lung function in IPF. Therefore, lung transplantation remains the only life-saving therapy available to treat patients with IPF. However, a shortage of suitable donor organs limits the number of affected individuals who can undergo this procedure, and this shortage highlights the need to allocate donor lungs to those who are in the greatest need of a life-saving therapy yet ensure that those who undergo transplantation will have a reasonable expectation of long-term survival. Still, outcomes remain relatively poor for many patients after lung transplantation, although a sizable minority of patients can enjoy long-term survival after lung transplantation.
has issue date	2013-09-13(xsd:dateTime)
bibo:doi	10.1007/978-1-62703-682-5_18
has license	no-cc
sha1sum (hex)	01c5c40b595137685135c23eb3ed541f0dfc2a22
schema:url	https://doi.org/10.1007/978-1-62703-682-5_18
resource representing a document's title	Lung Transplantation for Idiopathic Pulmonary Fibrosis
has PubMed Central identifier	PMC7121325
schema:publication	Idiopathic Pulmonary Fibrosis
resource representing a document's body	covid:01c5c40b595137685135c23eb3ed541f0dfc2a22#body_text
is schema:about of	named entity 'survival' named entity 'allocate' named entity 'Therefore' named entity 'However' named entity 'pharmaceutical agents' named entity 'therapies' named entity 'therapy' named entity 'improve' named entity 'donor' named entity 'IPF' named entity 'follow-up' named entity 'brosis' named entity '3.5' named entity 'FEV' named entity 'IPF' named entity 'lung transplantation' named entity 'Malignancy' named entity 'older patients' named entity 'lung transplant' named entity 'IPF' named entity 'IPF' named entity 'acute illness' named entity 'donor organ' named entity 'bilirubin' named entity 'lung transplantation' named entity 'IPF' named entity 'lung transplantation' named entity 'end-stage' named entity 'lung transplantation' named entity 'LAS' named entity 'IPF' named entity 'lung transplantation' named entity 'oxygen' named entity 'IPF' named entity 'IPF' named entity 'lungs' named entity 'lung transplantation' named entity 'lung transplantation' named entity 'carbon dioxide' named entity 'diabetes mellitus' named entity 'Latin American' named entity 'physical examination' named entity 'primary graft dysfunction' named entity '4.7' named entity 'high-risk' named entity 'survival time' named entity 'LAS' named entity 'lung transplantation' named entity 'donor organs' named entity 'utilitarian' named entity 'functional status' named entity 'IPF' named entity 'IPF' named entity 'IPF' named entity 'mortality rates' named entity 'Obesity' named entity 'lung transplant' named entity 'IPF' named entity 'idiopathic' named entity 'survival time' named entity 'adverse events' named entity 'kidney transplants' named entity 'pulmonary arterial hypertension' named entity 'obesity' named entity 'IPF' named entity 'organ damage' named entity 'IPF' named entity 'IPF' named entity 'histologic' named entity 'lung transplantation' named entity 'clinical practice' named entity 'lung transplantation' named entity 'mycobacteria' named entity 'lung transplantation' named entity 'pulmonary hypertension' named entity 'lung transplantation' named entity 'IPF' named entity 'human leukocyte antigens' named entity 'pediatric' named entity 'organ' named entity 'lung transplant' named entity 'OPTN'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software